噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析  

Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease

作　　者：陈文福[1] CHEN Wen-fu(Department of Respiratory,No.303 Hospital of the Chinese People's Liberation Army,Nanning 530021,Guangxi,China)

机构地区：[1]中国人民解放军第三〇三医院呼吸科,广西南宁530021

出　　处：《医学信息》2018年第2期124-125,共2页Journal of Medical Information

摘　　要：目的分析稳定期慢性阻塞性肺疾病应用噻托溴铵治疗的临床效果,观察患者各项指标恢复情况。方法采用数字随机法将2016年1月~2017年5月收治的慢性阻塞性疾病稳定期患者106例分成两组,各53例,对照组采用常规治疗,观察组患者采用噻托溴铵治疗,比较两组的临床效果及患者10 min步行距离、住院时间。结果观察组治疗总有效率94.34%,高于对照组的83.19%,差异有统计学意义(P<0.05);观察组患者住院时间为(6.15±1.19)d,少于对照组的(11.19±1.07)d,差异有统计学意义(P<0.05)。结论稳定期慢性阻塞性肺疾病应用噻托溴铵治疗的临床效果较好,患者的各项恢复情况明显,有效的缩短住院时间,减轻患者的痛苦及经济负担,值得临床推广。Objective To analyze the clinical effect of tiotropium in the treatment of chronic obstructive pulmonary disease(COPD)in stable phase and observe the recovery of various indexes in patients.Methods A total of 106 stable patients with chronic obstructive disease admitted from January 2016 to May 2017 were divided into two groups(n=53)by digital randomization method.Patients in the observation group were treated with tiotropium,patients in the observation group were treated with tiotropium.The clinical effects and the walking distance and hospital stay of 10 min were compared between the two groups.Results The total effective rate of observation group was 94.34%,which was higher than that of control group 83.19%,the difference was statistically significant(P<0.05);The length of hospital stay in the observation group was(6.15±1.19)d,which was less than that in the control group(11.19±1.07)d.The difference was statistically significant(P<0.05).Conclusion The clinical efficacy of tiotropium in patients with stable chronic obstructive pulmonary disease is better,and the recovery of patients is obvious,effectively shortening the hospital stay and alleviating the suffering and financial burden of patients,which is worthy of clinical promotion.

关 键 词：慢性阻塞性肺疾病 稳定期 噻托溴铵 

分 类 号：R563.9[医药卫生—呼吸系统]